We propose that the cDC1RS could be indicative of prognosis and predictive of the response to therapy such as ICIs and chemotherapy, potentially due to a synergistic interplay or cross-communication between cDC1 and CD8+ T cells in the context of GC. The gene discussed is CD8A; the disease is gastric cancer.